Clinical safety and pharmacokinetics of a novel oral niclosamide formulation compared with marketed niclosamide chewing tablets in healthy volunteers: A three-part randomized, doub... by Niklas Walther, Robert Schultz-Heienbrok, Heino Staß, Victor M Corman, Nils C Gassen, Marcel A Müller, Christian Drosten, Martin Witzenrath, Hweeling Lee, Maximilian G Posch

Get full text

Phase 1 Trials of Gatralimab, a Next-Generation Humanized Anti-CD52 Monoclonal Antibody, in Participants with Progressive Multiple Sclerosis by Fredrik N. Albach, Christian Geier, Christian Keicher, Maximilian G. Posch, Stephan J. Schreiber, Gerald Grütz, Levent Akyüz, Xiaodong Luo, Annaig Le-Halpere, Philippe Truffinet, Frank Wagner

Get full text

Atrial dysfunction: a contrast-free marker for HFpEF in obese diabetics—insights from comprehensive CMR and serum biomarker analyses by Rebecca Elisabeth Beyer, Maximilian Leo Müller, Patrick Doeblin, Stefanie Maria Werhahn, Amedeo Chiribiri, Carsten Tschöpe, Smita Sampath, G. Brandon Atkins, Dawn Cislak, An Bautmans, John Palcza, Tom McAvoy, Asad Abu Bakar, Anita Y. H. Lee, Xuemei Zhao, Maximilian G. Posch, Johannes Wieditz, Radu Tanacli, Victoria Zieschang, Mithal Nassar, Seyedeh Mahsa Zamani, Christian Stehning, Frank Edelmann, Djawid Hashemi, Sebastian Kelle

Get full text